CPIX
CPIX
NASDAQ · Pharmaceuticals

Cumberland Pharmaceuticals

$7.32
-0.23 (-3.05%)
As of Aug 8, 2:19 AM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +384.3% upside
Low Target $27.92
Average Target $35.45
High Target $53.56
Current Price $7.32
Current
$7.32
Target
$35.45
$27.92 $35.45 avg $53.56
Scenario Analysis
Bear Case
$27.92
281.4%
Low target
Base Case
$35.45
+384.3%
Avg target
Bull Case
$53.56
+631.7%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$8.23
-11.1% from high
52-Week Low
$1.85
+295.7% from low
Target vs 52W High
$35.45
+330.7% vs high
Next Earnings Report
Aug 11, 2026
2d
until earnings
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%